Skip to main content

Rapid therapy development through Open nCoronavirus Vaccine Platform

Project description

A DNA vaccine platform against SARS-CoV-2

Accumulating genetic evidence on the new SARS-CoV-2 virus shows that its envelope and receptor binding domain only share 75 % homology with other human coronaviruses. This indicates that existing immunotherapies and vaccine candidates against other coronaviruses will probably not work against SARS-CoV-2. To generate and select the most potent candidates that protect against SARS-CoV-2 infection, the EU-funded OPENCORONA project will use a DNA vaccine platform. The most promising leads will initially be validated in animal models of coronavirus infection and then tested in a phase I clinical trial for safety in healthy volunteers.

Coordinator

KAROLINSKA INSTITUTET
Net EU contribution
€ 423 067,89
Address
Nobels Vag 5
17177 Stockholm
Sweden

See on map

Region
Östra Sverige Stockholm Stockholms län
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00

Participants (6)

JUSTUS-LIEBIG-UNIVERSITAET GIESSEN
Germany
Net EU contribution
€ 185 860,00
Address
Ludwigstrasse 23
35390 Giessen

See on map

Region
Gießen Gießen, Landkreis
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00
FOLKHALSOMYNDIGHETEN
Sweden
Net EU contribution
€ 391 072,11
Address
Nobels Vag 18
171 82 Solna

See on map

Region
Östra Sverige Stockholm Stockholms län
Activity type
Other
Other funding
€ 0,00
IGEA SPA
Italy
Net EU contribution
€ 200 000,00
Address
Via Parmenide 10a
41012 Carpi Mo

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Nord-Est Emilia-Romagna Modena
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00
NORTHX BIOLOGICS MATFORS AB
Sweden
Net EU contribution
€ 1 200 000,00
Address
Box 219
864 23 Matfors

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Norra Sverige Mellersta Norrland Västernorrlands län
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00
ADLEGO BIOMEDICAL AB
Sweden
Net EU contribution
€ 200 000,00
Address
Box 42
751 03 Uppsala

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Östra Sverige Östra Mellansverige Uppsala län
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00
REGION STOCKHOLM
Sweden
Net EU contribution
€ 400 000,00
Address
Hantverkargatan 45
104 22 Stockholm

See on map

Region
Östra Sverige Stockholm Stockholms län
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Other funding
€ 0,00